Grifols has shared positive results from its clinical trial evaluating the efficacy and safety of intravenous immunoglobulin to treat patients with PPS.

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

Carson Block of Muddy Waters announced Grifols (GRFS) as a short idea for the Robin Hood contest, according to Bloomberg.Light Up your ...

Grifols shares lost more than 5% on the stock market on Monday. Last Friday, after the market had closed, a report was ...

Grifols (GRFS) issued a statement to address certain information published in a media outlet on March 8, specifically a front-page article ...

As European markets face uncertainty due to U.S. trade policy and recent ECB rate cuts, the pan-European STOXX Europe 600 Index has snapped a 10-week streak of gains, although increased defense and ...

CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future.06-March-2025 / 09:01 CET/CESTDisclosure of an inside information acc. to ...

European equities traded in the US as American depositary receipts were trending sharply higher late Wednesday morning, rising 1.72% to 1,443.47 on the S&P Europe Select ADR Index. From continental ...

More than two dozen people rallied on Monday against a for-profit clinic in Whitby that pays people for plasma ...

Canadian Blood Services (CBS) members are rallying in an Ontario town to protest new paid blood donation centres. The protest ...

Hamilton was declared a paid-plasma-free zone in June, but Canadian Blood Services and Spanish health-care company Grifols ...